The frequency, magnitude, and longevity of natural antibody responses against nine P. vivax vaccine candidate proteins

By | November 28, 2022
A new study aimed to evaluate the magnitude, longevity, and prevalence of naturally acquired IgG antibody responses against 9 P. vivax vaccine candidate antigens in patients with acute vivax malaria and were followed up for 180 days.